What is CARE Research?
Headquartered in Fort Collins, Colorado, CARE Research operates as a critical partner in the drug and medical device development lifecycle. The organization provides comprehensive preclinical services, including exploratory research and rigorous toxicology studies, utilizing a diverse array of animal models. By maintaining strict adherence to USDA and OLAW regulatory standards, the firm ensures that its research methodologies meet the highest benchmarks for humane treatment and scientific integrity. Its market reputation is built upon a foundation of competitive pricing models and highly efficient turnaround times, which are essential for clients navigating the complex regulatory pathways of modern drug development.
How much funding has CARE Research raised?
CARE Research has raised a total of $150K across 1 funding round:
Debt
$150K
Debt (2020): $150K with participation from PPP
Key Investors in CARE Research
PPP
Public-Private Partnership
What's next for CARE Research?
With this late-stage funding secured, CARE Research is poised to scale its infrastructure to meet the increasing demand for high-quality preclinical data. The strategic deployment of this capital will likely focus on enhancing laboratory throughput and potentially expanding its service portfolio to address emerging therapeutic modalities. As the pharmaceutical industry continues to prioritize speed-to-market, CARE Research's ability to provide reliable, compliant, and rapid in-vivo testing will remain a key competitive advantage. Future growth trajectories suggest a continued emphasis on operational excellence and the potential for further integration into the broader life sciences supply chain.
See full CARE Research company page
